share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

艾伯維公司 | 144：擬議出售證券
SEC announcement ·  03/19 05:07
牛牛AI助理已提取核心訊息
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
AbbVie Inc. officer Stewart Jeffrey Ryan is set to sell 58,949 common shares of the company on March 18, 2024, with an aggregate market value of approximately $10,539,878. The shares to be sold were acquired through stock option exercises and performance shares, both as compensation from the issuer. On March 18, 2024, Ryan acquired 26,110 shares via stock option exercise, and on February 28, 2024, he acquired 32,839 shares as performance shares. There is no reportable history of securities sold in the past three months prior to this notice.
艾伯維公司高管斯圖爾特·傑弗裏·瑞安定於2024年3月18日出售該公司的58,949股普通股，總市值約爲10,539,878美元。待出售的股票是通過股票期權行使和績效股票收購的，兩者都是發行人的補償。2024年3月18日，瑞安通過行使股票期權收購了26,110股股票，2024年2月28日，他收購了32,839股股票作爲績效股。在本通知之前的過去三個月中，沒有可申報的證券銷售記錄。
艾伯維公司高管斯圖爾特·傑弗裏·瑞安定於2024年3月18日出售該公司的58,949股普通股，總市值約爲10,539,878美元。待出售的股票是通過股票期權行使和績效股票收購的，兩者都是發行人的補償。2024年3月18日，瑞安通過行使股票期權收購了26,110股股票，2024年2月28日，他收購了32,839股股票作爲績效股。在本通知之前的過去三個月中，沒有可申報的證券銷售記錄。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。